HER2 overexpression is related to shorter disease-free survival; reduced survival time; decreased ER and PR expression; increased cell proliferation, migration, tumor invasiveness, frequency of metastases, and angiogenesis; and decreased apoptosis [6]. This evidence concerns the gene ERBB2 and neoplasm.